1. Home
  2. LGND vs CENT Comparison

LGND vs CENT Comparison

Compare LGND & CENT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • CENT
  • Stock Information
  • Founded
  • LGND 1987
  • CENT 1955
  • Country
  • LGND United States
  • CENT United States
  • Employees
  • LGND 68
  • CENT N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • CENT Consumer Specialties
  • Sector
  • LGND Health Care
  • CENT Consumer Discretionary
  • Exchange
  • LGND Nasdaq
  • CENT Nasdaq
  • Market Cap
  • LGND 2.2B
  • CENT 2.2B
  • IPO Year
  • LGND 1992
  • CENT N/A
  • Fundamental
  • Price
  • LGND $139.02
  • CENT $40.12
  • Analyst Decision
  • LGND Strong Buy
  • CENT Strong Buy
  • Analyst Count
  • LGND 8
  • CENT 2
  • Target Price
  • LGND $144.71
  • CENT $42.50
  • AVG Volume (30 Days)
  • LGND 139.7K
  • CENT 94.6K
  • Earning Date
  • LGND 08-05-2025
  • CENT 08-06-2025
  • Dividend Yield
  • LGND N/A
  • CENT N/A
  • EPS Growth
  • LGND N/A
  • CENT N/A
  • EPS
  • LGND N/A
  • CENT 1.87
  • Revenue
  • LGND $181,488,000.00
  • CENT $3,155,810,000.00
  • Revenue This Year
  • LGND $18.41
  • CENT $0.30
  • Revenue Next Year
  • LGND $18.87
  • CENT $1.78
  • P/E Ratio
  • LGND N/A
  • CENT $21.86
  • Revenue Growth
  • LGND 53.40
  • CENT N/A
  • 52 Week Low
  • LGND $81.74
  • CENT $31.97
  • 52 Week High
  • LGND $129.90
  • CENT $43.88
  • Technical
  • Relative Strength Index (RSI)
  • LGND 75.81
  • CENT 66.21
  • Support Level
  • LGND $120.68
  • CENT $39.38
  • Resistance Level
  • LGND $126.24
  • CENT $40.67
  • Average True Range (ATR)
  • LGND 4.48
  • CENT 1.02
  • MACD
  • LGND 1.87
  • CENT 0.48
  • Stochastic Oscillator
  • LGND 96.06
  • CENT 82.62

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About CENT Central Garden & Pet Company

Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.

Share on Social Networks: